Britt Lisa P. 4

What Happened Lisa P. Britt, Senior Vice President and Chief Human Resources Officer at Thermo Fisher Scientific (TMO), was credited with three awards on Feb 25, 2026 totaling 7,184 shares: 872 shares, 1,173 shares, and 5,139 shares (the last reported as a derivative). All awards show $0 cash paid (they are compensation awards, not open-market purchases). The company’s Compensation Committee determined on Feb 25, 2026 that performance criteria tied to the awards were satisfied.

Key Details

• Transaction date: 2026-02-25 (Filed: 2026-02-27; filing appears timely)
• Awards: 872 shares @ $0.00; 1,173 shares @ $0.00; 5,139 shares (derivative) @ $0.00 — total 7,184 shares
• Reported cash value: $0 (awarded stock/units as compensation)
• Shares owned after transaction: not specified in the filing
• Footnotes of the filing:
  • F1: The 5,139 shares represent a performance-based restricted stock unit (RSU) award granted Feb 19, 2025. Performance criteria were met on Feb 25, 2026. Vesting: one‑third on Feb 28, 2026, one‑third on Feb 28, 2027, and the final one‑third on Feb 28, 2028 (the final tranche is subject to upward or downward adjustment based on long‑term TSR performance vs. peers for 2025–2027).
  • F2: The filing also references an option vesting schedule (footnote): an option vests in four equal annual installments beginning Feb 28, 2027.

Context These entries reflect compensation awards (including performance-based RSUs/derivative units) rather than purchases or sales. Restricted stock units are rights to receive shares upon vesting, so some or all of these units will convert to actual shares only as they vest per the schedule and any performance adjustments. This type of filing is routine for executive compensation and does not, by itself, indicate buying or selling intent.